Lee, Mark H <br/><br/>
Considerations for tissue-engineered and regenerative medicine product development prior to clinical trials in the United States.  [electronic resource] 

 -  Tissue engineering. Part B, Reviews  Feb 2010 
 - 41-54 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1937-3376 
<br/><br/><label>Standard No.: </label>10.1089/ten.TEB.2009.0449  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Clinical Trials as Topic<br/>Drug and Narcotic Control<br/>Humans<br/>Regenerative Medicine--legislation & jurisprudence<br/>Tissue Engineering--legislation & jurisprudence<br/>United States<br/>United States Food and Drug Administration